Skip to main content
Clinical Trials/DRKS00015530
DRKS00015530
Recruiting
Not Applicable

Analysis of therapy-induced changes in gene expression, tumorigenicity and invasiveness of circulating, epithelial tumor cells (CETCs)

niversität Bayreuth0 sites100 target enrollmentSeptember 13, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C18
Sponsor
niversität Bayreuth
Enrollment
100
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 13, 2018
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversität Bayreuth

Eligibility Criteria

Inclusion Criteria

  • histologically verified, invasive colorectal carcinoma (C18, C19, C20\); initial diagnosis; stage I\-IV; medical treatment in the Hospital Bayreuth, only; minimum 2 blood withdrawals (before and after a guideline\-conform radio/chemotherapy or surgery)

Exclusion Criteria

  • lack of consent; unrelated, preceding malignancies \< 10 years before the diagnosis of the colorectal carcinoma; pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials